Results 201 to 210 of about 93,221 (259)

Cinobufotalin reduces glioblastoma resistance to temozolomide by inhibiting the CCL5-mediated PI3K/Akt/mTOR signaling pathway. [PDF]

Transl Cancer Res
Sun J, Ma X, Song J, Zhang Y, Li N, Li Y, Zhang X, Han Y.   +7 more
europepmc   +1 more source

A multi-database pharmacovigilance study reveals distinctive immunosuppressive and opportunistic infection disproportionality signals with bevacizumab and temozolomide combination therapy in glioblastoma. [PDF]

Front Med (Lausanne)
Yu Y, Hou X, Xu K.
europepmc   +1 more source

Variations in DNA Repair Genes and Intratumoral Genetic Heterogeneity in Temozolomide-Resistant Glioblastoma. [PDF]

Hum Mutat
Chen W, Li C, Liu Y, Huang H.
europepmc   +1 more source

Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response. [PDF]

Acta Neuropathol
Tlais D, Zhang Q, Roach JT, Tinkle CL, Lin T, Li X, Mostafa A, Moreira DC, McNall-Knapp RY, Rush SZ, Le BH, Sinno S, Ramnarayan A, Ginn KF, Partap S, Onar-Thomas A, Furtado LV, Bag AK, Chiang J.   +18 more
europepmc   +1 more source

Life-Threatening Radiation Necrosis After Complete Response to Pembrolizumab in a Patient With a Metastatic Silent PIT1 Pituitary Neuroendocrine Tumor (PitNET). [PDF]

J Immunother
De Alcubierre D, Feola T, Gianno F, Verrico M, Carbonara F, Venditti E, Isidori AM, Esposito V, Minniti G, Jaffrain-Rea ML.   +9 more
europepmc   +1 more source

Leptomeningeal metastasis from large-cell neuroendocrine carcinoma of the cervix: a case report and literature review. [PDF]

Front Oncol
Xu P, Wang ZJ, Dang XM, Zhu BY, Zheng ZC.   +4 more
europepmc   +1 more source

Characterization and clinical implications of CpG island methylator phenotypes of resistant tumors. [PDF]

Clin Epigenetics
Hou F, Zhou X, Huang YE, Liu H, Yuan M, Chen J, Wang Q, Jiang W.   +7 more
europepmc   +1 more source

Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutation. [PDF]

J Clin Invest
Li A, Sears TK, Horbinski CM.
europepmc   +1 more source

Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal Melanoma. [PDF]

J Otolaryngol Head Neck Surg
Ding Q, Wu J, Ding Y, Li D, Wen X, Jiang H, Chen L, Zhang Q, Zhang Y, Lu L, Zhang X, Li J.   +11 more
europepmc   +1 more source

Retraction Note: Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma. [PDF]

Cell Biosci
Zheng Y, Liu L, Wang Y, Xiao S, Mai R, Zhu Z, Cao Y.   +6 more
europepmc   +1 more source